(Q45735369)

15 December 2017

title

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration (English)

1 reference

15 December 2017

1 reference

1 reference

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

1 reference

Phuangsab A

1

1 reference

15 December 2017

Lorence RM

2

1 reference

15 December 2017

Reichard KW

3

1 reference

15 December 2017

Peeples ME

4

1 reference

15 December 2017

Walter RJ

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

15 December 2017

1 reference

15 December 2017

volume

172

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

27-36

1 reference

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Viruses as oncolytic agents: a new age for "therapeutic" viruses?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Scientific interest in Newcastle disease virus is reviving

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Newcastle disease virus: virus particle and RNA synthesis in different host cells and at different temperatures

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Newcastle disease virus selectively kills human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Strain variation and nuclear association of Newcastle disease virus matrix protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Viral oncolysate in the management of malignant melanoma. II. Clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900617-6

7 January 2021

10.1016/S0304-3835(01)00617-6

Identifiers

DOI

1 reference

15 December 2017

1 reference